Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO₂, and their nanocomposites as appropriate drug carriers

References

• Serajuddin TM. (1999). Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci, 88:1058–66.
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, James McGinity W, Williams ROIII. (2008). Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharm Res, 25:1450–9.
   PubMed Web of Science ®Google Scholar
• Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams ROIII. (2007). Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. Int J Pharm, 336:122–32.
   PubMed Web of Science ®Google Scholar
• Karavas E, Georgarakis E, Sigalas MP, Avgoustakis K, Bikiaris D. (2007a). Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions. Eur J Pharm Biopharm, 66:334–47.
   PubMed Web of Science ®Google Scholar
• Papageorgiou GZ, Bikiaris D, Kanaze FI, Karavas E, Stergiou A, Georgarakis E. (2008). Tailoring the release rates of fluconazole using solid dispersions in polymer blends. Drug Dev Ind Pharm, 34:336–46.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Karavas E, Georgarakis M, Docoslis A, Bikiaris D. (2007b). Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix. Int J Pharm, 340:76–83.
   PubMed Web of Science ®Google Scholar
• Papageorgiou GZ, Bikiaris D, Karavas E, Docoslis A, Stergiou A, Georgarakis E. (2006). Effect of physical state and particle size distribution on dissolution enhancement of nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. AAPS J, 8(4):E623–31.
   PubMed Web of Science ®Google Scholar
• Miller DA, McConville JT, Yang W, Williams ROIII, McGinity JW. (2007). Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci, 96:361–76.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. (1971). Pharmaceutical applications of solid dispersion system. J Pharm Sci, 60:1281–302.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersion. Pharm Res, 14:1691–8.
   PubMed Web of Science ®Google Scholar
• Friedrich H, Fussnegger B, Kolter K, Bodmeier R. (2006). Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. Eur J Pharm Biopharm, 62:171–7.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. (2004). Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Pow Tech, 141:187–95.
   Web of Science ®Google Scholar
• Watanabe T, Ono I, Wakiyama N, Kusai A, Senna M. (2002). Controlled dissolution properties of indomethacin by compounding with silica. STP Pharm Sci, 12:363–7.
   Google Scholar
• Pokharkar VB, Mandpe LP, Padamwar MN, Ambike AA, Mahadik KR, Paradkar A. (2006). Development, characterization and stabilization of amorphous form of low Tg drug. Pow Tech, 167:20–5.
   Web of Science ®Google Scholar
• Ambike AA, Mahadik KR, Paradkar A. (2005). Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: In vitro in vivo evaluations. Pharm Res, 22:990–8.
   PubMed Web of Science ®Google Scholar
• Sator K, Sator MO, Sator PG, Egarter C, Huber JC. (2006). Effects of tibolone on selectins in postmenopausal women. Maturitas, 53:166–70.
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ. (2004). Tissue-selective effects of tibolone on the breast. Maturitas, 49:S5–15.
   PubMed Web of Science ®Google Scholar
• Reeda MJ, Kloosterboer HJ. (2004). Tibolone: A selective tissue estrogenic activity. Maturitas, 48:S4–6.
   PubMed Web of Science ®Google Scholar
• Schatz F, Kuczynski E, Kloosterboer HJ, Buchwalder L, Tang C, Krikun G, . (2005). Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stroma l-cells. Evidence of progestogenic effects. Steroids, 70:840–5.
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ. (2001). Tibolone: A steroid with a tissue-specific mode of action. J Ster Biochem Mol Biol, 76:231–8.
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ. (2004). Tissue-selectivity: The mechanism of action of tibolone. Maturitas, 48(1):S30–40.
   PubMedGoogle Scholar
• De Haan P. (2004). Immediate-release pharmaceutical dosage form comprising polymorphous Tibolone. N.V. Organon 5340 BH Oss (NL), Proprietor: Akzo Nobel N.V. 6824 BM Arnhem (NL), EP 1 499 278 B1.
   Google Scholar
• Papadimitriou SA, Bikiaris D, Avgoustakis K. (2008). Microwave-induced enhancement of the dissolution rate of poorly water-soluble Tibolone from poly(ethylene glycol) solid dispersions. J Appl Polym Sci, 108:1249–58.
   Web of Science ®Google Scholar
• Kanaze FI, Kokkalou E, Niopas I, Georgarakis M, Stergiou A, Bikiaris D. (2006). Thermal analysis study of flavonoid solid dispersions having enhanched solubility. J Therm Anal Cal, 83:283–90.
   Web of Science ®Google Scholar
• Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. (2005). Role of molecular interactions in stability of celecoxib-PVP amorphous systems. Mol Pharm, 2:384–91.
   PubMed Web of Science ®Google Scholar
• Bikiaris D, Papageorgiou GZ, Stergiou A, Pavlidou E, Karavas E, Kanaze F, . (2005). Physicochemical studies on solid dispersions of poorly-water soluble drugs. Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta, 439:58–67.
   Web of Science ®Google Scholar
• Hu J, Rogers TL, Brown J, Young T, Johnston KP, Williams III RO. (2002). Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology. Pharm Res, 19:1278–84.
   PubMed Web of Science ®Google Scholar
• Sas GAJMT, van Doornum EM. (1991) .Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one. US Patent 5,037,817.
   Google Scholar
• Wang L, Cui FD, Sunada H. (2006). Preparation and evaluation of solid dispersions of Nitredipine prepared with fine silica particles using the melt-mixing method. Chem Pharm Bull, 54:37–43.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. (2005). Solid dispersion particles of amorphous indomethacin with fine porous silica particles by spray-drying method. Int J Pharm, 293:155–64.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Handa T, Kawashima Y. (1987). Spherical solid dispersion containing amorphous tolbutamide embedded in enteric coating polymers or colloidal silica prepared by spray-drying technique. Chem Pharm Bull, 5:3800–6.
   Google Scholar
• Hsiao CN, Huang KS. (2005). Synthesis, characterization, and applications of polyvinylpyrrolidone/SiO2 hybrid materials. J Appl Polym Sci, 96:1936–42.
   Web of Science ®Google Scholar
• Gun'ko VM, Voronin EF, Nosach LV, Pakhlov EM, Voronina OE, Guzenko NV, . (2006). Nanocomposites with fumed silica/poly(vinyl pyrrolidone) prepared at a low content of solvents. Appl Surf Sci, 253(5):2801–11.
   Web of Science ®Google Scholar